How do you solve a puzzle with hidden pieces? That’s the question researchers focused on pediatric Inflammatory bowel disease (IBD) face every day, as only 20% to 25% of their young patients under 5 years old present with a diagnosis-confirming genetic factor. Identifying the remaining children with the serious disorder presents a vast challenge.
ENGLEWOOD, Colo., Sept. 11, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced […]
Despite the pandemic, the elder woman seated in Adriana Zuniga’s, DDS, dental chair that day had traveled miles for a crown she’d been waiting months to get. Delaying care any longer for her and others […]
Thermo Fisher Scientific has been named Novo Nordisk’s contract manufacturer for Wegovy by an unnamed source, according to a Reuters report. Thermo Fisher and Novo Nordisk declined to comment to Endpoints News. Reuters reported Wednesday […]
Copyright © 2026 Biotech Networks
